Cleared Traditional

K132623 - MEDTRONIC CONFIDA BRECKER CURVE GUIDEWIRE

K132623 is an FDA 510(k) clearance for MEDTRONIC CONFIDA BRECKER CURVE GUIDEWIRE, manufactured by Medtronic. The device is a Class 2 Cardiovascular device with product code DQX cleared through the Traditional 510(k) pathway after a 119-day FDA review.

K132623 · Medtronic · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2013
Decision
119d
Days
Class 2
Risk

K132623 is an FDA 510(k) clearance for the MEDTRONIC CONFIDA BRECKER CURVE GUIDEWIRE. Classified as Wire, Guide, Catheter (product code DQX), Class II - Special Controls.

Submitted by Medtronic (Santa Rosa, US). The FDA issued a Cleared decision on December 19, 2013 after a review of 119 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1330 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Medtronic devices

FDA 510(k) Submission Details - K132623

510(k) Number K132623 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 22, 2013
Decision Date December 19, 2013
Days to Decision 119 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
6d faster than avg
Panel avg: 125d · This submission: 119d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQX Device Classification - Class 2, Special Controls

Product Code DQX Wire, Guide, Catheter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1330
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQX Wire, Guide, Catheter

All 681
Devices cleared under the same product code (DQX) and FDA review panel - the closest regulatory comparables to K132623.
MANDREL GUIDEWIRE
K140485 · Lake Region Medical · Mar 2014
ASAHI GAIA FIRST, SECOND, THIRD
K133865 · Asahi Intecc Co., Ltd. · Mar 2014
VDRIVE WITH V-SONO
K133396 · Stereotaxis, Inc. · Feb 2014
INQWIRE DIAGNOSTIC GUIDE WIRE
K133230 · Merit Medical Systems, Inc. · Dec 2013
MEDIVALVE ACWIRE
K132545 · Medivalve , Ltd. · Nov 2013
HORIZON XVU (FFR)
K123792 · Mennen Medical , Ltd. · Aug 2013